Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SMMT |
---|---|---|
09:32 ET | 7450 | 4.525 |
09:34 ET | 10797 | 4.5559 |
09:36 ET | 6004 | 4.5933 |
09:38 ET | 10247 | 4.62 |
09:39 ET | 4722 | 4.59 |
09:41 ET | 9875 | 4.575 |
09:43 ET | 3100 | 4.565 |
09:45 ET | 6543 | 4.56 |
09:48 ET | 35766 | 4.53 |
09:50 ET | 3178 | 4.53 |
09:52 ET | 11185 | 4.53 |
09:54 ET | 1924 | 4.545 |
09:56 ET | 2215 | 4.5262 |
09:57 ET | 4297 | 4.5094 |
09:59 ET | 2714 | 4.495 |
10:01 ET | 12005 | 4.475 |
10:03 ET | 2150 | 4.475 |
10:06 ET | 1100 | 4.475 |
10:08 ET | 1388 | 4.445 |
10:10 ET | 3659 | 4.455 |
10:12 ET | 3009 | 4.45 |
10:14 ET | 400 | 4.465 |
10:15 ET | 6647 | 4.44 |
10:17 ET | 1136 | 4.45 |
10:19 ET | 3453 | 4.45 |
10:21 ET | 9442 | 4.458 |
10:24 ET | 300 | 4.47 |
10:26 ET | 9306 | 4.46 |
10:28 ET | 1581 | 4.455 |
10:30 ET | 7673 | 4.44 |
10:32 ET | 4903 | 4.425 |
10:33 ET | 1600 | 4.43 |
10:35 ET | 8126 | 4.415 |
10:37 ET | 4973 | 4.4378 |
10:39 ET | 1763 | 4.42 |
10:42 ET | 20954 | 4.415 |
10:44 ET | 2900 | 4.45 |
10:46 ET | 900 | 4.46 |
10:50 ET | 2044 | 4.445 |
10:51 ET | 2609 | 4.435 |
10:53 ET | 5945 | 4.4201 |
10:55 ET | 315 | 4.425 |
10:57 ET | 1900 | 4.44 |
11:00 ET | 1181 | 4.455 |
11:02 ET | 1207 | 4.45 |
11:04 ET | 950 | 4.45 |
11:08 ET | 8219 | 4.445 |
11:09 ET | 1615 | 4.455 |
11:11 ET | 168 | 4.4506 |
11:13 ET | 100 | 4.45 |
11:15 ET | 602 | 4.44 |
11:18 ET | 399 | 4.435 |
11:20 ET | 4459 | 4.445 |
11:22 ET | 200 | 4.445 |
11:24 ET | 790 | 4.446 |
11:26 ET | 3800 | 4.445 |
11:27 ET | 400 | 4.445 |
11:29 ET | 700 | 4.4409 |
11:31 ET | 600 | 4.445 |
11:33 ET | 10006 | 4.47 |
11:36 ET | 1998 | 4.49 |
11:38 ET | 4006 | 4.495 |
11:40 ET | 7298 | 4.495 |
11:42 ET | 2050 | 4.4997 |
11:44 ET | 1599 | 4.4941 |
11:45 ET | 7025 | 4.49 |
11:47 ET | 4262 | 4.485 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Summit Therapeutics Inc | 3.2B | -2.9x | --- |
Apogee Therapeutics Inc | 3.1B | -31.0x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
Xenon Pharmaceuticals Inc | 3.1B | -14.8x | --- |
Biohaven Ltd | 3.3B | -5.5x | --- |
Iovance Biotherapeutics Inc | 3.0B | -5.9x | --- |
Summit Therapeutics Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of patient, physician and caregiver medicinal therapies. The Company's development candidate is ivonescimab, a potential first-in-class bispecific antibody intending to combine the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects of an anti-VEGF compound into a single molecule. It develops ivonescimab in non-small cell lung cancer (NSCLC), specifically launching Phase III clinical trials in the indications such as ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (HARMONi), and ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (HARMONi-3). Its ivonescimab is engineered with Akeso's Tetrabody technology.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.2B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 702.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -1.26 |
EPS | $-1.54 |
Book Value | $0.11 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.